相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
Tomáš Šimůnek et al.
Pharmacological Reports (2014)
Mechanism of anthracycline-mediated down-regulation of GATA4 in the heart
Ah-Mee Park et al.
CARDIOVASCULAR RESEARCH (2011)
Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53
Chi Zhang et al.
CARDIOVASCULAR RESEARCH (2011)
MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1
Huaqing Zhu et al.
CARDIOVASCULAR RESEARCH (2011)
Pegylated Liposomal Doxorubicin A Review of its use in Metastatic Breast Cancer, Ovarian Cancer, Multiple Myeloma and AIDS-Related Kaposi's Sarcoma
Sean T. Duggan et al.
DRUGS (2011)
Adiponectin Ameliorates Doxorubicin-induced Cardiotoxicity through Akt Protein-dependent Mechanism
Sonomi Maruyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
MST1 Promotes Apoptosis through Regulating Sirt1-dependent p53 Deacetylation
Fang Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Redox Modulation of p53: Mechanisms and Functional Significance
Do-Hee Kim et al.
MOLECULAR CARCINOGENESIS (2011)
Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity
J. Huelsenbeck et al.
CELL DEATH & DISEASE (2011)
Anti-Fas Gene Therapy Prevents Doxorubicin-Induced Acute Cardiotoxicity through Mechanisms Independent of Apoptosis
Shusaku Miyata et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Nox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy
Youyou Zhao et al.
CANCER RESEARCH (2010)
Doxorubicin Cardiomyopathy
Kanu Chatterjee et al.
CARDIOLOGY (2010)
Sirtuin1-p53, forkhead box O3a, p38 and post-infarct cardiac remodeling in the spontaneously diabetic Goto-Kakizaki rat
Erik Vahtola et al.
CARDIOVASCULAR DIABETOLOGY (2010)
Deficiency of Rac1 Blocks NADPH Oxidase Activation, Inhibits Endoplasmic Reticulum Stress, and Reduces Myocardial Remodeling in a Mouse Model of Type 1 Diabetes
Jianmin Li et al.
DIABETES (2010)
Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice
Rajarajan A. Thandavarayan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Histone Deacetylase-3 Activation Promotes Tumor Necrosis Factor-α (TNF-α) Expression in Cardiomyocytes during Lipopolysaccharide Stimulation
Huaqing Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cardiomyocyte death in doxorubicin-induced cardiotoxicity
Yi-Wei Zhang et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2009)
NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis
Mylene Gilleron et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Reactive oxygen species-independent apoptosis in doxorubicin-treated H9c2 cardiomyocytes: Role for heme oxygenase-1 down-modulation
Francesca Bernuzzi et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Rac1 Is Required for Cardiomyocyte Apoptosis During Hyperglycemia
E. Shen et al.
DIABETES (2009)
Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity
Masashi Yoshida et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Simvastatin reduces Chlamydophila pneumoniae-mediated histone modifications and gene expression in cultured human endothelial cells
Bernd Schmeck et al.
CIRCULATION RESEARCH (2008)
Heat Shock Protein 20 Interacting With Phosphorylated Akt Reduces Doxorubicin-Triggered Oxidative Stress and Cardiotoxicity
Guo-Chang Fan et al.
CIRCULATION RESEARCH (2008)
Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species
Hideki Sumimoto
FEBS JOURNAL (2008)
Role of anthracyclines in the era of targeted therapy
Hernan Cortes-Funes et al.
CARDIOVASCULAR TOXICOLOGY (2007)
Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage
Connie Chao et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation
Shinji Kume et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Requirement of Rac1 in the development of cardiac hypertrophy
Minoru Satoh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Regulation of NADPH oxidases - The role of Rac proteins
PL Hordijk
CIRCULATION RESEARCH (2006)
Molecular composition and regulation of the Nox family NAD(P)H oxidases
H Sumimoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
The antitumor anthracyclines doxorubicin and daunorubicin do not inhibit cell growth through the formation of ironmediated reactive oxygen species
X Wu et al.
ANTI-CANCER DRUGS (2005)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
DNA double-strand breaks and γ-H2AX signaling in the testis
G Hamer et al.
BIOLOGY OF REPRODUCTION (2003)
MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation
YT Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
p300/CBP/p53 interaction and regulation of the p53 response
SR Grossman
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2
A Ito et al.
EMBO JOURNAL (2001)
Histone deacetylases specifically down-regulate p53-dependent gene activation
LJ Juan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases
YJ Kang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Rho family proteins modulate rapid apoptosis induced by cytotoxic T lymphocytes and Fas
MC Subauste et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
